In colorectal cancer, we and others observed that inhibiting Mitogen-Activated Protein Kinase Kinase (MEK) rapidly activates the epidermal growth factor receptor (EGFR), which synergistically enhances AKT signaling6,7. The gene discussed is EGFR; the disease is colorectal cancer.